Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections.

Cell | 2016

Monkeypox (MPXV) and cowpox (CPXV) are emerging agents that cause severe human infections on an intermittent basis, and variola virus (VARV) has potential for use as an agent of bioterror. Vaccinia immune globulin (VIG) has been used therapeutically to treat severe orthopoxvirus infections but is in short supply. We generated a large panel of orthopoxvirus-specific human monoclonal antibodies (Abs) from immune subjects to investigate the molecular basis of broadly neutralizing antibody responses for diverse orthopoxviruses. Detailed analysis revealed the principal neutralizing antibody specificities that are cross-reactive for VACV, CPXV, MPXV, and VARV and that are determinants of protection in murine challenge models. Optimal protection following respiratory or systemic infection required a mixture of Abs that targeted several membrane proteins, including proteins on enveloped and mature virion forms of virus. This work reveals orthopoxvirus targets for human Abs that mediate cross-protective immunity and identifies new candidate Ab therapeutic mixtures to replace VIG.

Pubmed ID: 27768891 RIS Download

Associated grants

  • Agency: NIH HHS, United States
    Id: P51 OD011092
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000445
  • Agency: BLRD VA, United States
    Id: I01 BX001444
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK058404
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI48512
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI109948
  • Agency: NCI NIH HHS, United States
    Id: P30 CA068485
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024975
  • Agency: NIAID NIH HHS, United States
    Id: HHSN272200900047C

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GraphPad Prism (tool)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

IMGT - the international ImMunoGeneTics information system (tool)

RRID:SCR_012780

A high-quality integrated knowledge resource specialized in the immunoglobulins (IG) or antibodies, T cell receptors (TR), major histocompatibility complex (MHC) of human and other vertebrate species, and in the immunoglobulin superfamily (IgSF), MHC superfamily (MhcSF) and related proteins of the immune system (RPI) of vertebrates and invertebrates, serving as the global reference in immunogenetics and immunoinformatics. IMGT provides a common access to sequence, genome and structure Immunogenetics data, based on the concepts of IMGT-ONTOLOGY and on the IMGT Scientific chart rules. IMGT works in close collaboration with EBI (Europe), DDBJ (Japan) and NCBI (USA). IMGT consists of sequence databases, genome database, structure database, and monoclonal antibodies database, Web resources and interactive tools.

View all literature mentions

Mouse Anti-Human IgG4 Fc-AP Antibody (antibody)

RRID:AB_2687999

This monoclonal targets Human IgG4 myeloma protein

View all literature mentions

Mouse Anti-Human IgG3 Hinge-AP Antibody (antibody)

RRID:AB_2687998

This monoclonal targets Human IgG3 myeloma protein

View all literature mentions

Mouse Anti-Human IgG1 Hinge-AP Antibody (antibody)

RRID:AB_2687996

This monoclonal targets Human IgG1 Hinge

View all literature mentions

Mouse Anti-Human IgG2 Fc-AP Antibody (antibody)

RRID:AB_2687997

This monoclonal targets Human IgG2 myeloma protein

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

CBySmn.Cg-Prkdcscid/J (organism)

RRID:IMSR_JAX:001803

Mus musculus with name CBySmn.Cg-Prkdcscid/J from IMSR.

View all literature mentions

BSC40 (cell line)

RRID:CVCL_3656

Cell line BSC40 is a Spontaneously immortalized cell line with a species of origin Chlorocebus pygerythrus (Vervet monkey)

View all literature mentions

RK 13 (cell line)

RRID:CVCL_3155

Cell line RK 13 is a Spontaneously immortalized cell line with a species of origin Oryctolagus cuniculus

View all literature mentions

Vero (cell line)

RRID:CVCL_0059

Cell line Vero is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions

Vero C1008 (cell line)

RRID:CVCL_0574

Cell line Vero C1008 is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions

GenePix Pro (software resource)

RRID:SCR_010969

Industry standard microarray image analysis software because of its unique combination of imaging and analysis tools, visualizations, automation capabilities, performance and intuitive workflows.

View all literature mentions

PRISM (data analysis service)

RRID:SCR_005375

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.

View all literature mentions